Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children

Salvador Resino1, Rosa Resino, José Maria Bellón

  • 1Laboratorio de Inmuno-Biología Molecular, Hospital General Universitario Gregorio Marañón, Madrid, Spain. sresino.hgugm@salud.madrid.org

Insights

Highly active antiretroviral therapy (HAART) significantly reduced AIDS cases, deaths, and hospitalizations in vertically HIV-1 infected children. This effective treatment protocol improved CD4 counts and viral load, enhancing overall clinical outcomes.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Public Health

Background:

  • Antiretroviral therapy (ART) has improved outcomes for children with human immunodeficiency virus type 1 (HIV-1).
  • Effectiveness of different ART protocols on clinical outcomes in children requires ongoing evaluation.
  • Vertical HIV-1 transmission poses significant health challenges in pediatric populations.

Purpose of the Study:

  • To evaluate the effectiveness of various antiretroviral therapy protocols on clinical outcomes in vertically HIV-1 infected children.
  • To assess changes in CD4(+) cell counts, viral load, and adverse clinical events over distinct treatment eras.

Main Methods:

  • Retrospective study of 427 vertically HIV-1 infected children.
  • Follow-up divided into five calendar periods (CPs) reflecting evolving ART strategies (pre-ART, monotherapy, combination therapy, partial HAART, full HAART).
  • Analysis of clinical outcomes including AIDS incidence, mortality, hospital admissions, and hospitalization duration.

Main Results:

  • Significant improvements in CD4(+) cell count and viral load observed from 1997 onwards with HAART.
  • CP5 (1999-2003), with >60% HAART use, showed significantly lower AIDS cases (2%) and deaths (0.5%) compared to earlier periods.
  • HAART era (CP4 & CP5) demonstrated >3.5 relative risk for no hospital admission and reduced hospitalization duration.

Conclusions:

  • Highly active antiretroviral therapy (HAART) is highly effective in reducing adverse clinical outcomes in vertically HIV-1 infected children.
  • Transition to HAART protocols led to substantial decreases in AIDS incidence, mortality, and hospitalizations.
  • Findings support the critical role of HAART in managing pediatric HIV-1 infection, as demonstrated in Madrid, Spain.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...